Metlife Inc (NYSE:MET) shares, rose in value, with the stock price up by 1.14% to the previous day’s close as strong demand from buyers drove the stock to $77.61.
Actively observing the price movement in the recent trading, the stock is buoying the session at $76.74. The PE ratio was 12.64 over 12-month period. Referring to stock’s 52-week performance, its high was $89.05, and the low was $65.21. On the whole, MET has fluctuated by 13.44% over the past month.
With the market capitalization of Metlife Inc currently standing at about $52.10 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 2.20, with its dividend yield at 2.84%.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MET’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 1.07, with the price of MET currently trading nearly 4.13% and -0.46% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.31, while the 7-day volatility ratio is showing 2.30% which for the 30-day chart, stands at 3.61%. Furthermore, Metlife Inc (MET)’s beta value is 0.84, and its average true range (ATR) is 2.48.
A comparison of Metlife Inc (MET) with its peers suggests the former has fared considerably weaker in the market. MET showed an intraday change of 1.14% in today’s session so far, and over the past year, it grew by 9.03%%.
Data on historical trading for Metlife Inc (NYSE:MET) indicates that the trading volumes over the past 3 months, they’ve averaged 3.76 million. According to company’s latest data on outstanding shares, there are 673.29 million shares outstanding.
Nearly 16.36% of Metlife Inc’s shares belong to company insiders and institutional investors own 77.05% of the company’s shares. The stock has fallen by -5.21% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MET stock heading into the next quarter.
